Uncontrolled intraoperative bleeding is one of the oldest problems in surgery, and surgical hemostatic agents remain one of the primary tools used to manage it when direct pressure, sutures, or electrocautery are not enough on their own. These agents span a wide range of chemistries and mechanisms, from absorbable materials that create a physical scaffold for clot formation to sealants that mimic the final steps of the body's own clotting cascade. Because no single product suits every bleeding scenario, most operating rooms stock several categories side by side, and surgeons select among them based on the tissue involved, the bleeding rate, and the surgical field.
This guide walks through the major categories of surgical hemostatic agents in general use, how they are generally understood to work, and the kinds of considerations that typically inform product selection during a procedure.
What Counts as a Surgical Hemostatic Agent?
Broadly, hemostatic agents are materials applied directly to a bleeding surface to help the body form a stable clot faster or more reliably than it might unassisted. They are distinct from systemic medications that affect clotting throughout the body; instead, they act locally, at the site of tissue injury. Common categories include:
- Absorbable materials such as oxidized regenerated cellulose, which provide a matrix that supports platelet aggregation
- Flowable hemostatic matrices that can be shaped into irregular wound beds
- Fibrin sealants that combine two components to replicate the final clotting step
- Topical thrombin preparations
- Bone wax, used specifically on cut bone surfaces
- Cyanoacrylate tissue adhesives, which polymerize on contact with tissue moisture to help support hemostasis and closure in appropriate wounds
Each category has different absorption profiles, application methods, and typical use cases, which is why surgical teams are trained to recognize which situations call for which agent.
How Do Surgeons Decide Which Hemostatic Agent to Use?
Selection generally depends on several factors working together rather than any single rule. The type of tissue matters: bone, liver parenchyma, and vascular anastomoses each behave differently and tend to favor different agent classes. The rate and volume of bleeding also matters, since a diffuse ooze from a raw surface is handled differently than a focal bleeding point. Other considerations commonly include whether the surface is irregular (favoring a flowable matrix), whether rapid sealing plus tissue apposition is needed (favoring a tissue adhesive), and whether the material will remain in the body long-term or needs to be resorbed within a defined period.
Ultimately, this decision rests with the operating surgeon, who weighs the clinical picture in real time. No hemostatic agent is a substitute for careful surgical technique, and manufacturer labeling for every product should be reviewed before use.
Where Do Tissue Adhesives Fit Into the Hemostasis Toolkit?
Cyanoacrylate-based tissue adhesives occupy a somewhat distinct role compared to absorbable sponges or matrices. Rather than simply supporting clot formation, an adhesive like Texten is described by its manufacturer as a fast-acting cyanoacrylate adhesive intended for wound closure, surgical tissue bonding, hemostasis, and tissue sealing. According to manufacturer-reported information, polymerization begins approximately 1–2 seconds after application to tissue and completes in about 5 seconds, forming a flexible bond. Site materials describe this category of product as suited to operations where there is a possibility of bleeding or leakage, a general framing that should be confirmed against the specific product's Instructions for Use (IFU) for any given case.
Are Hemostatic Agents Used the Same Way Across Every Specialty?
Not typically. Cardiac, hepatobiliary, orthopedic, and general surgery teams each tend to gravitate toward particular categories based on the tissues they most often encounter. A liver resection team may lean on flowable matrices for a large raw parenchymal surface, while an orthopedic team might reach for bone wax on a cut sternal or long-bone edge. These patterns are not fixed rules, and many centers maintain multiple categories in inventory precisely so the surgeon can match the agent to the bleeding pattern encountered.
What is the main purpose of a surgical hemostatic agent?
Surgical hemostatic agents are applied locally during a procedure to help support the body's own clotting process at a bleeding site. They are generally used as an adjunct to standard surgical techniques such as pressure, ligation, or cautery, rather than as a replacement for them.
Are all hemostatic agents absorbable?
No. Some categories, such as oxidized regenerated cellulose and gelatin-based flowable matrices, are designed to be absorbable over time, while others, such as certain tissue adhesives, are intended to remain functional as a bond during healing. Absorption characteristics vary by product and should be confirmed in the manufacturer's IFU.
Can a hemostatic agent replace sutures entirely?
Not generally. In select, appropriate wounds, adhesives such as cyanoacrylate-based products may support sutureless closure, but suitability depends on wound location, tension, and depth. A qualified surgeon determines whether an adhesive, sutures, or a combination approach is appropriate for a given wound.
INVAMED's hemostatic tissue sealant solutions portfolio spans several of the categories described above, reflecting the reality that most surgical teams need access to more than one type of agent.
Device availability and regulatory status vary by country. Please contact INVAMED or your authorized local distributor for current regulatory information applicable to your region.